Table 3.
N | No coronary calcium N=78 | Coronary calcium N=27 | Combined N=105 | P value | |
---|---|---|---|---|---|
GDF‐15 pg/mL | 93 | 512 [293–928] | 1155 [658–1662] | 656 [347–1088] | <0.001* |
IL‐1β pg/mL | 100 | 0.20 [0.17–0.24] | 0.16 [0.14–0.24] | 0.19 [0.16–0.24] | 0.1 |
IL‐6 pg/mL | 102 | 1.38 [0.94–1.81] | 1.48 [1.05–1.76] | 1.41 [0.99–1.80] | 0.4 |
IL‐10 pg/mL | 102 | 0.31 [0.25–0.45] | 0.27 [0.23–0.39] | 0.30 [0.24–0.44] | 0.2 |
IFN‐γ pg/mL | 102 | 5.4 [4.1–8.2] | 6.5 [5.8–11.7] | 6.0 [4.3–9.4] | 0.03* |
TNF‐α pg/mL | 102 | 1.23 [1.00–1.38] | 1.41 [1.00–1.60] | 1.26 [1.00–1.46] | 0.1 |
N is the number of nonmissing values. Test used: Wilcoxon test. GDF‐15 indicates growth differentiation factor 15; IFN‐γ, interferon‐γ; PWH, persons with HIV; and TNF‐α, tumor necrosis factor α.
Statistical significance defined as P<0.05.